
As Avicanna prepares to report its earnings, investors are keenly watching to see if the company can reverse its recent trend of disappointing results.
Scheduled for release on August 12, 2026, after market close, Avicanna Inc (AVCN.TO) will unveil its financial performance for the second quarter of fiscal 2026. With an EPS consensus estimate of -$0.26 and a revenue expectation of $2.30 million, the upcoming report is pivotal for the company’s trajectory amidst a challenging market environment.
Recent earnings trend
Advertisement
Avicanna Inc
AVCN.TO
AVCN.TO
Avicanna Inc
Advertisement
Market cap
$16.98M
52W high
$0.30
52W low
$0.10
1W change
+4.00%
Beta
0.33
Analyst Price Targets
Based on analyst covering AVCN
Wall Street analysts forecast AVCN stock price to rise 438.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.70
+438.5% Upside
Current Price
C$0.13
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCN's historical volatility
30-Day Vol
71.7%
Annualized
90-Day Vol
65.0%
Annualized
Trend (90d)
+16.5%
Annualized drift
90d Mean
C$0.14
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.13 | C$0.10 – C$0.17 |
| 60 trading days | C$0.14 | C$0.10 – C$0.19 |
| 90 trading days | C$0.14 | C$0.09 – C$0.21 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Analyst coverage: 1 analyst(s) cover this name; upcoming EPS consensus is available.
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-13 | -0.0078 | — | — |
| 2025-09-30 | 2025-11-13 | -0.0116 | — | — |
| 2025-06-30 | 2025-08-14 | -0.0070 | — | — |
| 2025-03-31 | 2025-05-14 | 0.0004 | — | — |
| 2024-09-30 | 2024-11-14 | -0.0087 | — | — |
| 2024-06-30 | 2024-08-14 | -0.0188 | — | — |
Advertisement
Investor takeaway: Investors should closely monitor Avicanna's upcoming earnings report for signs of improvement in revenue growth and operational efficiency, particularly given the company's history of missing earnings estimates.
EPS Consensus at -$0.26, Historical Trends Show 0 Beats in Last 4 Quarters
Avicanna has not beaten earnings estimates in its last four comparable quarters, with consistent misses raising concerns among investors about its operational effectiveness.
Bull case
If Avicanna can effectively leverage its recent product launches and strategic investments, it may begin to show signs of revenue growth. This could lead to a more optimistic outlook and potentially bring the company closer to profitability.
Bear case
Given the company's history of missing earnings estimates, any further disappointment in the upcoming report could shake investor confidence and negatively impact the stock price.
Advertisement
Advertisement

Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.


